
Curasight A/S — Investor Relations & Filings
Curasight A/S is a clinical-stage biotechnology company focused on improving the diagnosis and treatment of various cancers. The company is developing a novel theranostic platform targeting the urokinase-type plasminogen activator receptor (uPAR), a biomarker for cancer aggressiveness. This platform integrates two main components: uTRACE®, a diagnostic agent for precise Positron Emission Tomography (PET) imaging, and uTREAT®, a targeted radionuclide therapy. The uTRACE® diagnostic identifies patients with uPAR-positive tumors, enabling subsequent treatment with uTREAT®. This approach aims to deliver radiation directly to cancer cells, minimizing exposure to healthy tissue and providing a more gentle and efficient therapeutic option. The company's technology is being advanced through multiple phase II clinical trials.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Udnyttelse af tegningsretter Curasight TO i Curasight A/S | 2025-05-15 | Danish | |
| Udnyttelse af tegningsretter Curasight TO i Curasight A/S | 2025-05-15 | English | |
| Udnyttelse af tegningsretter Curasight TO i Curasight A/S | 2025-05-15 | Danish | |
| Udnyttelse af tegningsretter Curasight TO i Curasight A/S | 2025-05-15 | English | |
| Udnyttelse af tegningsretter Curasight TO i Curasight A/S | 2025-05-15 | Danish | |
| Udnyttelse af tegningsretter Curasight TO i Curasight A/S | 2025-05-15 | English |
Browse filings by year
2 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cellectis
Develops allogeneic, or 'off-the-shelf', CAR T-cell immunot…
|
ALCLS | FR | Manufacturing |
|
Cellid Co., Ltd.
Develops immunotherapeutic vaccines for cancer and infectio…
|
299660 | KR | Manufacturing |
|
Cellromax Science Co., Ltd.
Researches and develops health foods, derma-cosmetics, and …
|
471820 | KR | Manufacturing |
|
CellSeed Inc.
Develops and commercializes cell sheet engineering for rege…
|
7776 | JP | Manufacturing |
|
Celltrion, Inc.
Biopharmaceutical firm developing biosimilars for autoimmun…
|
068270 | KR | Manufacturing |
|
Celltrion Pharm Inc.
Manufactures and supplies chemical pharmaceuticals and bios…
|
068760 | KR | Manufacturing |
|
CELLUMED CO., LTD.
Develops and manufactures medical devices, tissue grafts, a…
|
049180 | KR | Manufacturing |
|
Celon Pharma S.A.
An integrated pharmaceutical company researching and manufa…
|
CLN | PL | Manufacturing |
|
Celularity Inc
Develops allogeneic cell therapies and biomaterials from th…
|
CELU | US | Manufacturing |
|
Cenra Inc.
Diversified healthcare enterprise providing R&D, manufactur…
|
3716 | TW | Manufacturing |
Curasight A/S via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7159/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7159 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7159 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7159 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7159}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Curasight A/S (id: 7159)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.